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FISCHBACH, P.S., ET AL.: Use of a Single Coil Transvenous Electrode with an Abdominally Placed Im-
plantable Cardioverter Defibrillator in Children. While transvenous defibrillaior electrode placement
avoiding a thoracotomy is preferable, electrode size, a large intercoil spacing, and the need for subclavic-
ular device placement preclude this approach in mo.'it children. We investigated a single RV coil to an ab-
dominally placed active can ICD device. Five children ages 8-16 years (weight 21-50 kg. mean 35 kg) un-
derwent ICD placement. Placement of a single coil Medtronic model 6932 or 6943 electrode was performed
via the left subclavian vein approach and the electrode positioned in the HV apex with the coil lying along
the RV diaphragmatic surface. The ICD (Medtronic Micro Jewel II model 7223Cx) was implanted in a left
abdominal pocket with the lead tunneled from the infraclavicular region to the pocket. Implant DFTs were
^ 15 f using a biphasic waveform. DFTs rechecked within 3-month postimplant were unchanged. Lead
impedance at implant ranged from 38 to 56 fl, mean 51 fl. Follow-up was 3-21 months (total 82 months)
with no electrode dislodgment. lead fractures, or inappropriate discharges. Two of the five patients have
had successful appropriate ICD discharges. Transvenous ICD electrode placement can be performed in
children as small as 20 kg with the device implanted in a cosmetically acceptable abdominal pocket that
is well tolerated. Fxcellent DFTs can be achieved. This approach avoids a thoracotomy in all hut the
smallest child, does not require subclavicular placement of the device, and avoids use of a second in-
travascular coil. (PACE 2000; 23:884-887)
defibrillator, children, arrhythmia, abdominal implant
Introduction
The value of implantable cardioverter defibril-
lators [ICDs) as a lifesaving intervention has beon
previously demonstrated in the pediatric popula-
tion/ The experience with ICDs in this age group is
limited, accounting for less than 1% of all im-
planted devices.^ Similar to the indications for de-
vice implantation in adult patients as outlined re-
cently by the American College of Cardiology and
the American Heart Association,^ the need for an
ICD in the pediatric population arises from one of
three causes: (1) primary electrical disease [con-
genital long QT syndrome, idiopathic ventricular
fibrillation fVF]); (2) cardiomyopathy [arrhythmo-
genic right ventricular dysplasia, hypertrophic, di-
lated); and [3) following repair of congenital heart
disease (tetralogy of Fallot, transposition of the
great arteries). Previously, the size of the transve-
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nous electrodes and the long intershocking coil dis-
tance have been prohibitively large for transvenous
ICD placement in smaller pediatric patients, and.
therefore, required epicardial patch electrode
placement. New, smaller diameter single coil leads
using the device as the second high voltage elec-
trode have heen developed, allowing the placement
of endocardial systems in smaller patients.^ De-
spite recent reductions in the size of ICDs, they re-
main unacceptably large for infraclavicular place-
ment in small patients due to cosmetic and comfort
concerns. Similar problems have been resolved in
pediatric patients [including infants) requiring per-
manent cardiac pacing by implantin;^ the pace-
maker in an abdominal location. Whereas this im-
plant site would accommodate the large device, its
location raises the question as to its ability to defib-
rillate the heart with this new electrode configura-
tion. This article documents the safety and efficacy
of an ICD system using a single coil transvenous
electrode and the abdominally implanted device as
the second high voltage electrode.
Methods
Five children [Table I), ages 8-ir> years and
weighing 21-50 kg, underwent ICD placement fol-
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DOB = data of birth; AAI = age at implant (years); TD = therapy delivered; TOF = tetralogy of fallot; CL = cycle length; HOCM
hypertrophic obstructive cardiomyopathy; LOTS = long QT syndrome; VT = ventricular tachycardia.
lowing a syncopal event with documented ventric-
ular tachycardia (patients 1-4) or prophylactically
in a patient with hypertrophic cardiomyopathy
(patient numher 5). A single coil Medtronic model
6932 or 6943 electrode {Medtronic Inc, Min-
neapolis, MN, USA) was placed via a 10 Fr intro-
ducer accessing tho left subclavian vein. The elec-
trode was positioned in the right ventricular apex
so that the coil lay along the right ventricular di-
aphragmatic surface. The ICD (Medtronic Micro
Jewel II model 7223Cx) was implanted in the oper-
ating room under general anesthesia in a suhcuta-
neous pocket created in the left upper quadrant.
The lead [75-100 cm) was tunneled from the infr-
aclavicular region along the anterior axillary line
to the pocket [Fig. 1). Defihrillation thresholds
[DFTs) were determined at the time of implant and
repeated within 3 months in all patients. The pa-
tients were seen in follow-up at 6-montli intervals,
and their devices were interrogated at each visit.
Results
At the time of implant, the DFTs ranged from
5 to 15 ) [mean 9 J) with no significant changes at
3-month postimplantation retesting [range 10-20
J, mean 14 J). Lead impedance measured at im-
plant ranged from 38 to 56 ft (mean 51 ft). Follow-
np for 3-21months [total 82 months) has heen free
of electrode dislodgment, lead fractures, or inap-
propriate discharges. To date, two of the five pa-
tients have had successful, appropriate ICD dis-
charges. The remaining three patients have had no
device discharges and no symptoms suggestive of
recurrent tachyarrhythmias
There were no complications related to the
placement of the electrode or ICD. The lone sys-
tem complication occurred in patient 3 who ini-
tially underwent placement of a dual coil shock-
ing electrode and was found to have a fracture in
the proximal shocking coil that did not affect the
sensing capabilities of the lead or the function of
the distal coil. Due to the long intershocking coil
distance relative to the size of the patient, the
Figure 1. Location of the implantable cardioverter
defibrillator (ICD) and course of the defihrillator lead in
patient 5. The lead is tunneled from the left
infraclavicular region to the left upper abdominal pocket
in the operating room. The principle stress points on the
lead art! where the lead passes between the clavicle and
the first rib, and where the lead passes over the edge of
the lower costal margin.
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Figure 2. (A) A chest radiograph shortly after the placement of the implantable curdioverter
defibrillator (ICD) system in patient 3. Due to the patient's small size relative to the intercoil
distance, the proximal coil was left extending beyond the entrance site in the subclavian vein. fB)
A subsequent chest radiograph demonstrating a fracture of the proximal high voltage coil an it
passes between the clavicle and the first rib (arrow).
proximal coil extended beyond the entry site in
the subclavian vein and between the head of the
left clavicle and the first rib [Fig. 2), The proximal
coil could not be advanced further into the in-
nominate vein at initial implant as this caused dis-
lodgment of the distal electrode in the right ven-
tricle. The device was reprogrammed to shock
between the device and the distal coil. The patient
had successful appropriate therapies prior to and
after the reprogramming of the device.
Discussion
The implantation of ICDs in pediatric patients
is infrequent. However, due to advances in disease
recognition, broader acceptance of the device's use
in children, and improvements in device technol-
ogy, their use is increasing. One factor encouraging
acceptance of ICDs is the production of smaller de-
vices and endocardial lead systems permitting the
placement of transvenous ICDs. These devices
eliminate the need for a thoracotomy and its asso-
ciated morbidity in all but the smallest patients.''
While the smallest devices currently available
have been reduced to < 40 cubic centimeters
(Medtronic Gem DR, CPI Mini IV), this volume still
remains prohibitively large for pectoral implanta-
tion in smaller pediatric patients due to comfort
and cosmetic reasons. Similar concerns were pre-
viously addressed for the implantation of perma-
nent pacing systems in infants and small children.
The solution was to place the pulse generator in a
pocket in the abdominal wall, which can more eas-
ily accommodate the large device relative to the
patient's body. This approach has also been used
when placing ICD devices in smaller oatients us-
ing epicardial or dual coil lead systems. The effi-
cacy and safety of an ICD configuration using a sin-
gle coil intracardiac electrode witb an abdominally
placed device acting as tho second high voltage
electrode has not previously been reported.
Zipes and colleagues^ first demonstrated that
the fibrillating heart requires a minimal myocar-
dial mass he depolarized by an electrical shock to
achieve successful defibrillation. One advantage
of ICD systems witb epicardial defibrillation
patches is their anatomic relation to the ventricles
directing the defibrillation energy vector across
the ventricular myocardium. In a transvenous lead
system with the defibrillating pulse :oassing be-
tween two intravascular high voltage t:oils or be-
tween the coils and a pectorally located device,
the energy vector is directed anteriorly and supe-
riorly away from the ventricular septum and the
left ventricle. As would be expected, transvenous
lead systems have higher energy requirements for
defibrillation'^ and ICD implantation frequently
was unsuccessful due to these high DFTs. The ad-
vent of biphasic defibrillating shock waveforms
lessened this problem hy lowering thfi amount of
energy required to dofibrillate the heart.''*' While
the DFTs using a biphasic waveform remain
higher in a transvenous system compa::'ed with an
opicardial system, tho difference is not excessive.*"
With the high voltage electrode configuration
used in this study, the energy vector is altered fur-
ther still. The energy wave is directed inferiorly
and anteriorly, further away from the mass of tbe
left ventricle and interventricular septum. There-
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fore, one concern of this electrode arrangement is
tbat an unacceptable small mass of myocardium
would be depolarized at clinically acceptable en-
ergy outputs and thus defibrillation rendered less
likely. Despite this altered energy vector, we
demonstrated that low DFTs were obtainable (^15
J) and that these values were stable at follow-up
testing. The clinical efficacy of this system has
been confirmed by the two patients who have ex-
perienced successful appropriate ICD discharges
with restoration of sinus rhythm.
Further concerns have been raised in regards
to lead durability. The lead is particularly vulnera-
ble as it passes between the clavicle and rib cage,
and as it passes over the lower costal margin to
the abdominal pocket. With the exception of pa-
tient 3, where the proximal shocking coil was en-
Irapped between the clavicle and tbe first rib,
no problems bave been observed with the leads im-
planted in these five patients. This complication
was considered to be a function of the long
intercoil distance leaving the larger diameter, less
flexible coil in this vulnerable position. While
the follow-up in patient years is small in this series,
we also have not experienced any lead fractures in
a larger cohort of patients with dual coil systems
and abdominally implanted devices. Additionally,
the system benefits in comparison with an epicar-
dial patch system by having an endocardial sensing
lead making the detection and discrimination of
malignant ventricular arrhythmias more sensitive.
In summary, we have demonstrated that
transvenous ICD placement can be performed in
children as small as 20 kg using a single coil RV
electrode with the device implanted in a cosmeti-
cally acceptable, well-tolerated abdominal pocket
serving as the second high voltage electrode. Low
DFTs can he achieved and are maintained at fol-
low-up. This approach avoids a thoracotomy in all
but the smallest child, does not require subclavic-
ular placement of the device, and avoids use of a
second intravascular coil.
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